All AbMole products are for research use only, cannot be used for human consumption.
Acipimox (K-9321) is a nicotinic acid analogue with anti-lipid and anti-lipolysis effects. Acipimox can acutely inhibit lipolysis, inhibit free fat levels throughout the body and improve insulin sensitivity.
Acipimox (0-100 µM; 0-4 hours) enhances leptin release from adipocytes isolated from Sprague-Dawley rats in a time- and dose- dependent manner. Acipimox (10 mM) stimulats leptin release in adipocytes from Streptozotocin (STZ)-treated and Zucker diabetic fat (ZDF) rats. Acipimox (50 mg/kg; i.p.) significantly lowers circulating free fatty acid (FFA) and glucose in high-fat fed mice.
| Molecular Weight | 154.12 |
| Formula | C6H6N2O3 |
| CAS Number | 51037-30-0 |
| Solubility (25°C) | DMSO ≥ 50 mg/mL Wate 12 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Related Products |
|---|
| Poly-L-lysine (MW 150000~300000)
Poly-L-lysine |
| N-Phenylacrylamide
N-Phenylacrylamide |
| Silver diethyldithiocarbamate
Silver diethyldithiocarbamate is used in conjunction with Fe2+ to detect NO in brain, kidney, liver, and other tissues. |
| Methylmalonic acid
Methylmalonic acid can be used as a substrate in esterification reactions by various catalysts. |
| Sarcosine
Sarcosine is a glycine transporter type 1 (GlyT) inhibitor and an N-methyl-D-aspartate (NMDA) receptor co-agonist at the glycine binding site. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
